ATMI — Investor Presentation (May 2013)
22 slides from ATMI's investor presentation, May 29, 2013
Slide 1: Process Innovator to Global Technology Leader
PROCESS INNOVATOR TO GLOBAL TECHNOLOGY LEADER Investor Presentation May 2013 ©2013 ATM In. Al rights reserved. @ ATM |
Slide 2: Safe Harbor Statement
Safe Harbor Statement I's fi fi including, without limitation, ited results of anaraiions or level of business for 2013 or any ‘other jie ene are re terarth looking statements within the statements are based on current expectations only and are subject to certain risks, uncertainties, and assumption
Slide 3: Company Overview
Company Overview
Slide 4: About ATMI
3 Au) 5 fe o > fo) > ci o 2 iS i} °o About ATMI > Global al Lechnoleay compan' ‘onsumables + Founded in 1986; IPO in 1993 (NASDAQ: ATMI) Headquarters: Danbury, CT > Global development, manufacturing and support Market: leading positions Well-developed IP ee + High-performing pro + Long-term, i tala
Slide 5: Highly Developed Global Infrastructure
2 ‘=I = £ 3 ° 2 Ss cc ra © g oo 9 @ oO Highly Developed Global Infrastructure Microelectronics market Pa Revenues by Geography @ Sales, Marketing and Application Support Asia 69% . © Product Development Center O = = North Amer 41996 @ Manufacturing and Operations > Headquarters Investing to Better A
Slide 6: A Strong Foundation
A Strong Foundation Technical Depth a a rs} S @ 2 € 3 Ss) g io o (s) Technology roadmap management > > Global : an ; Infrastructure > Regional application expertise > Customer iti higher yields and performance > Pp Intellectual > Assets > Leveraging Technology + Infrastructure To Address Growth Oppo
Slide 7: Strategic Priorities
Strategic Priorities Lifes — leverage intellectual property and technology in biopharmaceutica industry adoption of single-u use technology hihi ©2013 ATM nc. Al rights reserved. @ ATM I
Slide 8: Evolution of Technology Investments
Evolution of Technology Investments > & oO g g s a 2008 2013 Future Where We WERE Where We ARE Where We’re GOING © ¢€c¢ = Microelectronics ™ LifeSciences = Other | than wafer starts side Microelectronics Growing Portion Of Revenues And Profits Derive ©2013 ATM Inc Al sights reserved. @ ATM I
Slide 9: Business Segment Overview
Business Segment Overview
Slide 10: Business Evolution
Business Evolution Growth Platform Overview _ > Advanced node i iti technology and Microelectronics ‘olutions leader 5 — P Investing in Single-Use technology materials ; knowledge Technology > J Transfer > Primary supplier Resource to world’s largest semiconductor > ) manufacturers electronic waste
Slide 11: Strong Franchise With Solid Growth And Margins
Strong Franchise With Solid Growth And Margins > Industry-leading position achieved a coe ling high-performance Microelectronics Revenues ($M. $336 $351 $366 $370 > Critical supplier to the industry; customers include Top logic and memory producers * Top foundries 2010 2011 2012 1.2013 LTM > + Utili
Slide 12: Advanced Materials
Advanced Materials Chips Becoming More Complex... 140 1600 105 1200 70 800 35 400 65nm_ 45/40nm32/28nm22/20nm 14nm Mim Materials (Left) —=Processes Steps (Right) ATMI Microelectronics Well-Pos' Source: ATMI Marketing, Semico Research .-And More Reliant On Materials {Relevant impact on performance] 5
Slide 13: Innovative Technologies
Innovative Technologies ading Market Position: Implant Gas Delivery Systems Advanced Photo Resist Packaging Copper Plating Chemistry Copper Post-Etch Cleans Chemistry Advanced Copper Post-CMP Cleans Chemistry Emerging node CVD, ALD Parca and vaporization technologi ©2013 ATM, inc. All rights reserve
Slide 14: LifeSciences
LifeSciences Lifesciences Approaching Breakeven And Poised For Growth > Single-Use concepts based on film LifeSciences Revenues ($M. $42 $44 fabrication and packaging technology $38 i $31 > Single-Use sisal pal for lower cost drug development and manufacturing while improving di Santee and efficienc
Slide 15: LifeSciences: Single-Use Technology Market and M&A History
LifeSciences 1 . AGR hing CAR RY 2NIN SUT 4 y ble SUT Market ($B)* > LifeSciences profitable by Q4 2013 $36 > Revenue sataada ? 20% - 30% over the Estimated next t several y CAGR ~S0% ms pel reaching inflection point $06 jeted and personalized drug Soa sot sone 3020 + Drug potency and concentration
Slide 16: LifeSciences
LifeSciences Seasoned History And A Bright Future SUT Equipment & > > Classified as higher Consumables > IP currently comprises 7% of revenue er <—, BO yj 0 — 30% Annual Grow ©2013 ATM Inc Al ights reserved. @ ATM I
Slide 17: The Next Chapter...
The Next Chapter... challenges . Gold 340 grams Silver 3.5 kilograms Palladium 140 grams Copper 130 kilograms > fs) = zor 2 = iy] 9 2 =) 3 a g 3 w J = iS = = ) a a fe) et) = po Gi] £ ai Further di fi growth potential i ss ss ; revenues by 2016 X “Estimated 1 Billion Produced Annually. nvestment In T
Slide 18: Financial Highlights
Financial Highlights ©2013ATMI, ne All rights reserved, <Q ATM I
Slide 19: Income Statement
= 2 5 = g $ S) g J = & = z Income Statement > Revenues 3% CAGR (vs. flat wafer starts) Operating Income growing >2x faster than revenue * Operating Income 11% CAGR SDS Direct transaction improves profitability Another example of M&A capability LifeSciences and Resource Efficiency growtl + Balance sh
Slide 20: Strong Balance Sheet To Fund Future Growth
Strong Balance Sheet To Fund Future Growth 3 2 2 ¢ Cash ($M) > 6 > strona a Sate cash positio (Inc. Marketable Securities! a in 2011 driven by SosM SDS S Dee ‘ransaction in Q4.2011 oss s169 an a * Q1 2013 decline due to timing of some uta =| payments and changes in working = ital > No debt 2010 2011
Slide 21: Clear, Realistic Financial Objectives
Clear, Realistic Financial Objectives 3 ae S 2 G > ° > . - a Revenue than wafer start: 2 es. ifs 209 y < é > > Operating margin >20% by H2 2014 each segment > perations ~$20M per quarter 2016 Committed To Growth, Driven By Proven Technology and Enabled People ©2013 ATM, inc. All rights reserved. @ A
Slide 22: Well-Positioned in Microelectronics, Growing in LifeSciences
Well-Positioned in Microelectronics, Growing in LifeSciences > Strong, = J £ & = a 2 = G £ a a g > & Efficiency > Strong customer time to market Proven acquirer LifeSciences mind A Compelling Model To Build Shareholder Value ©2013 ATM Inc Al ights reserved. @ ATM I